These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17451611)

  • 1. Treatment of patients with Eisenmenger's syndrome with Bosentan.
    Brun H; Thaulow E; Fredriksen PM; Holmstrom H
    Cardiol Young; 2007 Jun; 17(3):288-94. PubMed ID: 17451611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in exercise capacity and cardiac performance in a series of patients with Eisenmenger's syndrome transitioned from selective to dual endothelin receptor antagonist.
    Kopeć G; Tyrka A; Miszalski-Jamka T; Mikołajczyk T; Waligóra M; Guzik T; Podolec P
    Heart Lung Circ; 2012 Nov; 21(11):671-8. PubMed ID: 22819097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience with bosentan therapy in patients with the Eisenmenger syndrome.
    Christensen DD; McConnell ME; Book WM; Mahle WT
    Am J Cardiol; 2004 Jul; 94(2):261-3. PubMed ID: 15246919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.
    Galiè N; Beghetti M; Gatzoulis MA; Granton J; Berger RM; Lauer A; Chiossi E; Landzberg M;
    Circulation; 2006 Jul; 114(1):48-54. PubMed ID: 16801459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease.
    Diller GP; Dimopoulos K; Kaya MG; Harries C; Uebing A; Li W; Koltsida E; Gibbs JS; Gatzoulis MA
    Heart; 2007 Aug; 93(8):974-6. PubMed ID: 17639112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of bosentan in adults with simple and complex Eisenmenger's syndrome.
    Williams R; Houser L; Miner P; Aboulhosn J
    Congenit Heart Dis; 2012; 7(1):12-5. PubMed ID: 22188797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease.
    Kotlyar E; Sy R; Keogh AM; Kermeen F; Macdonald PS; Hayward CS; McNeil KD; Celermajer DS
    Cardiol Young; 2006 Jun; 16(3):268-74. PubMed ID: 16725066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of treatment with bosentan in adult Eisenmenger's syndrome patients with Down's syndrome related to congenital heart disease.
    Crepaz R; Romeo C; Montanaro D; De Santis S
    BMC Cardiovasc Disord; 2013 Sep; 13():74. PubMed ID: 24047157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pulmonary vasodilator therapy on ventilatory efficiency during exercise in adults with Eisenmenger syndrome.
    Yang-Ting S; Aboulhosn J; Sun XG; Child JS; Sietsema KE
    Congenit Heart Dis; 2011; 6(2):139-46. PubMed ID: 21418531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of an endothelin receptor antagonist in Eisenmenger syndrome: a single-center experience of 11 patients].
    Poindron D; Godart F; Duhamel A; Richard A; Francart C; Brevière GM; Rey C
    Arch Mal Coeur Vaiss; 2006 May; 99(5):457-62. PubMed ID: 16802735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease.
    Apostolopoulou SC; Manginas A; Cokkinos DV; Rammos S
    Heart; 2005 Nov; 91(11):1447-52. PubMed ID: 15761050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study.
    Gatzoulis MA; Beghetti M; Galiè N; Granton J; Berger RM; Lauer A; Chiossi E; Landzberg M;
    Int J Cardiol; 2008 Jun; 127(1):27-32. PubMed ID: 17658633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.
    Mehta PK; Simpson L; Lee EK; Lyle TA; McConnell ME; Book WM
    Tex Heart Inst J; 2008; 35(3):256-61. PubMed ID: 18941642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.
    Berger RM; Beghetti M; Galiè N; Gatzoulis MA; Granton J; Lauer A; Chiossi E; Landzberg M
    Int J Cardiol; 2010 Oct; 144(3):373-8. PubMed ID: 19464064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of bosentan therapy on cardiac function and symptomatic benefits in adult patients with Eisenmenger syndrome.
    Kaya MG; Lam YY; Erer B; Ayhan S; Vatankulu MA; Nurkalem Z; Meric M; Eren M; Eryol NK
    J Card Fail; 2012 May; 18(5):379-84. PubMed ID: 22555267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eisenmenger's syndrome in a 27 week pregnancy--management with bosentan and sildenafil.
    Molelekwa V; Akhter P; McKenna P; Bowen M; Walsh K
    Ir Med J; 2005 Mar; 98(3):87-8. PubMed ID: 15869069
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and tolerability of bosentan in adults with Eisenmenger physiology.
    Gatzoulis MA; Rogers P; Li W; Harries C; Cramer D; Ward S; Mikhail GW; Gibbs JS
    Int J Cardiol; 2005 Jan; 98(1):147-51. PubMed ID: 15676179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study.
    Apostolopoulou SC; Manginas A; Cokkinos DV; Rammos S
    Heart; 2007 Mar; 93(3):350-4. PubMed ID: 16980516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial.
    Iversen K; Jensen AS; Jensen TV; Vejlstrup NG; Søndergaard L
    Eur Heart J; 2010 May; 31(9):1124-31. PubMed ID: 20202971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.